NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/07/2026
Back to search
Official data from USPTO
BIOXPEDIA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
BIOXPEDIA
ST13
US500000079377424Class
35, 42, 44
Filing
79377424
Registration
7646444
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
05/08/2026
Classification
Registered
Trademark type
Word
Nice classes
35, 42, 44
Filing date
05/30/2023
Registration date
01/14/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/14/2025
Last transaction
05/08/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DK
Examiner
SWAIN, MICHELE LYNN
Law office
M70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
BioXpedia A/S
Representatives
Rhett V. Barney Lee & Hayes, PC
Technical classification
Nice Classes
Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Provision of business statistical information relating to medical matters; compilation of statistical data relating to medical research for business purposes; compilation of statistics for business purposes; business assistancemanagement and administrative services; compilation of medical reports for business purposes
Class 42
Analytical laboratory serviceslaboratory research services in the field of biomarker discovery and validation for drug development; scientific and technological servicesproviding assays and analytical methods for clinical researchdrug discoverydevelopment; research relating to molecular sciencesspecifically research involving molecular diagnosticsgenomicsproteomics for personalized medicine; genetic research specifically human genetic research focusing on gene expression profilinggenome-wide association studiesgenetic biomarker discovery; biological analysis; medical and pharmacological research services; biology consultancy; biological research; biological development services specifically development and optimization of biological assays and protocols for preclinical and clinical trials; biochemistry research services; laboratory services specifically for the analysis of proteinsnucleic acidssmall molecules using mass spectrometryqPCRELISA; laboratory servicesspecifically for the analysis of proteinsnucleic acidssmall molecules using mass spectrometryqPCRdPCRELISA; biomedical research services; structural and functional analysis of genomes; natural science servicesnatural science servicesscientific research in the fields of biochemistrymolecular biologypharmacology; medical research; medical research laboratory services; research in the field of gene therapyincluding vector developmentgene editingdelivery mechanisms for therapeutic purposes; scientific research in the field of genetics; laboratory research in the field of gene expression; research in the field of gene editing technologyparticularly using CRISPR-Cas9 and other gene-editing tools for therapeutic applications and functional genomics studies; scientific research for medical purposes in the area of cancerous diseases; dna conducting of scientific feasibility studies; DNA screening for scientific research purposes; DNA analysis to determine paternity; research and development services in the field of gene expression systems; analysis of human serum for medical research; analysis of human tissues for medical research; scientific research relating to the isolation and cultivation of human tissues and cells; cell culture services for scientific and research purposesfor others; toxicity analysisin vitro and in vivo toxicity testing of pharmaceuticals and chemical compounds for safety and efficacy assessments; toxicity testing for scientific research purposes; testing of pharmaceuticals for scientific research; blood analysis services for scientific research purposes
Class 44
Human healthcare services; medical laboratory analysis services relating to the treatment of persons; medical laboratory services for the analysis of samples taken from patients; medical laboratory services for the analysis of blood samples taken from patients; medical analysis services relating to the treatment of persons provided by a medical laboratory; medical services; medical screening; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical consultations; medical information; medical diagnostic services; medical counseling; providing medical information; issuing of medical reports; genetic testing for medical purposes; medical and health services relating to dnagenetics and genetic testing; medical analysis services for the diagnosis of cancer; DNA screening for medical purposes; RNA and DNA analysis for cancer diagnosis and prognosis for medical purposes; analysis of human serum for medical treatment; medical testing of urine; analysis of human tissues for medical treatment; medical treatment using cultured cells; cultured cell bank services for medical transplantation
Publications
History of USPTO decisions and trademark events.
27 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/08/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/21/2025
FIMP
FINAL DISPOSITION PROCESSED
07/21/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/14/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
02/15/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/27/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/26/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/14/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
01/14/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/26/2024
PUBO
PUBLISHED FOR OPPOSITION
11/26/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/20/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/18/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/18/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/18/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/18/2024
RFNT
REFUSAL PROCESSED BY IB
04/08/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/19/2024
RFRR
REFUSAL PROCESSED BY MPU
03/19/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/28/2024
CNRT
NON-FINAL ACTION WRITTEN
02/27/2024
DOCK
ASSIGNED TO EXAMINER
02/22/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/25/2023
MAFR
APPLICATION FILING RECEIPT MAILED
09/05/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/01/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/31/2023
Continuous trademark protection
Get notified about every new filing that threatens BIOXPEDIA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.